Wells Fargo
INBX icon

Wells Fargo’s Inhibrx INBX Stock Holding History

Wells Fargo’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Buy
9,563
+5,625
+143% +$564K ﹤0.01% 4180
2026
Q1 		$265K Sell
3,938
-6,875
-64% -$510K ﹤0.01% 4531
2025
Q4 		$854K Buy
10,813
+3,214
+42% +$219K ﹤0.01% 4090
2025
Q3 		$256K Buy
7,599
+1,133
+18% +$27.9K ﹤0.01% 4789
2025
Q2 		$92.3K Sell
6,466
-315
-5% -$4.07K ﹤0.01% 5242
2025
Q1 		$94.9K Buy
6,781
+134
+2% +$1.82K ﹤0.01% 5125
2024
Q4 		$102K Buy
6,647
+1,695
+34% +$25.8K ﹤0.01% 5193
2024
Q3 		$77.5K Buy
4,952
+431
+10% +$6.06K ﹤0.01% 5160
2024
Q2 		$64.1K Buy
+4,521
New +$70.6K ﹤0.01% 5190

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's INBX Position: Q2 2026 in Review

Wells Fargo increased its Inhibrx (INBX) stake by 143% in Q2 2026, buying an estimated $564K and bringing the position to 9,563 shares worth $906K. The position accounts for ﹤0.01% of the portfolio, ranked #4180.

Wells Fargo first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Wells Fargo held 9,563 shares of Inhibrx worth $906K as of Q2 2026.
  • Wells Fargo bought 5,625 Inhibrx shares in Q2 2026, an estimated $564K.
  • Inhibrx made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4180 holding.
  • Wells Fargo first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.